@FierceBiotech: Trending--Sanofi CEO Viehbacher now calls beloved Boston biotech hub his home. More | Follow @FierceBiotech
@JohnCFierce: No. 1 - $31M; No. 2 - $8M: 2013's 10 best-compensated R&D chiefs in biopharma. Report | Follow @JohnCFierce
@DamianFierce: Science pays: 2013's 10 best-compensated R&D chiefs in biopharma. Feature | Follow @DamianFierce
@EmilyMFierce: Genetically engineered malaria parasite could expedite vaccine development. ICYMI from FierceBiotech Research | Follow @EmilyMFierce
> Waltham, MA-based Repligen has acquired Refine Technology with a mix of cash and stock worth $24.5 million. Story
> Morris Birnbaum joined Pfizer ($PFE) as CSO for cardio and metabolic disease research. Birnbaum had been a professor at the Perelman School of Medicine at the University of Pennsylvania and was also an investigator in the Howard Hughes Medical Institute. Release
> Alachua, FL-based Nanotherapeutics secured a $30 million loan facility from Hercules Technology Growth Capital. Release
Medical Device News
@FierceMedDev: Singapore team designs nanotech glaucoma treatment for sustained release. Story from FierceDrugDelivery | Follow @FierceMedDev
@VarunSaxena2: The EU continues to talk medical device reform. What will the finished regulations look like? More from The National Law Review | Follow @VarunSaxena2
@MichaelGFierce: 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Learning a second language could help ward off dementia, say researchers @UniofEdinburgh. More | Follow @EmilyWFierce
> GE wins FDA approval for automated breast imaging system . News
> Pixium Vision looks to raise $45M in European IPO. Article
> Former ArthroCare top execs convicted of securities fraud scheme. Article
Pharma News
@FiercePharma: Catch this week's issue of FiercePharmaMarketing here. Issue | Follow @FiercePharma
@TracyStaton: Novartis nabs Merck exec Bruno Strigini to head up oncology business. More | Follow @TracyStaton
@EricPFierce: RT from @FiercePharma: Smells like team spirit: AstraZeneca CEO says Pfizer fight has it pumped to perform. Story | Follow @EricPFierce
@CarlyHFierce: Out with the old, in with the new: Merck, GSK, others put established drugs on the block. News | Follow @CarlyHFierce
@JustinHFierce: #NPPCWPX THE WORLD PORK EXPO HAS A MEDIA ROOM. | Follow @JustinHFierce
> Where has all the Big Pharma marketing money gone? Emerging markets. More
> Medicare opens door wide for Gilead's $84K hep C drug Sovaldi. Story
> Persevering in Eastern Europe despite unrest, Stada eyes more deals. News
Drug Delivery News
> 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More
> Singapore team designs nanotech glaucoma treatment for sustained release. Article
> First cheek-bound film for opioid dependence nears PDUFA date. Report
> Investors watch RNA therapy companies for signs of future profits. Item
> FDA approves first nasally delivered gel for 'Low T.' Story
Diagnostics News
> Quest and Memorial Sloan-Kettering team for next-generation gene sequencing. Report
> Five urine biomarkers may offer a new way to spot male infertility. Item
> Provista broadens ASU cancer biomarker licensing deal. More
> NanoString to produce companion test for Celgene's blockbuster cancer drug Revlimid. Article
> Almac at ASCO: Dx spots ovarian cancer patients for whom Roche's Avastin would hurt. Story
Pharma Marketing News
> Pfizer launches next new Lipitor copay program, Medicare and ACA included. Report
> GlaxoSmithKline's Chinese reps demand to be repaid for bribes, FT reports. More
> Novartis, Merck KGaA use digital tracking in MS patients to up their competitive game. Story
> AstraZeneca's Crestor gets a boost from Cigna data-crunching deal. Article
> Pfizer launches next new Lipitor copay program, Medicare and ACA included. More